Targeting the cancer kinome through polypharmacology

a | Mechanisms of acquired resistance. treatment with kinase inhibitors can select for mutations that block drug binding (left panel). this was first demonstrated for the T315I mutation in BCR–ABL in chronic myeloid leukaemia. treatment with a kinase inhibitor can induce upregulation of a second kinase that substitutes for the drug target (centre panel). The receptor tyrosine kinase MET (also known as hepatocyte growth factor receptor) has been shown to be overexpressed in lung cancer cells that acquire resistance to epidermal growth factor receptor (EGFR) inhibitors. Tumour cells can respond to treatment with a kinase inhibitor by down-regulating the phosphatase that normally dephosphorylates the substrates of that kinase (right panel). This has the effect of decreasing the cellular potency of the kinase inhibitor. this mechanism has been observed in acquired resistance to EGFR inhibitors in breast cancer cells. b | Mechanisms of intrinsic resistance. Many tumours express multiple oncogenic kinases that signal redundantly to promote cell survival (left panel). For example, some gliomas show constitutive activation of multiple receptor tyrosine kinases. Mutational activation of a downstream pathway component can reduce the effectiveness of a kinase inhibitor (right panel). KRAS mutations are associated with resistance to EGFR inhibitors in lung and colorectal cancer–. IGF1R, insulin-like growth factor 1 receptor; INSR, insulin receptor; P, phosphorylation.
Targeting the cancer kinome through polypharmacology

Publication

Targeting the cancer kinome through polypharmacology. () Zachary A. Knight, et al. Nat Rev Cancer. ;10(2):130-137. Figure: F1.

Gene mentions


Organism Group Word Match Source NCBI Symbol NCBI ID
Homo sapiens Primates BCR-ABL BCR-ABL ncbigene_synonym ABL1 25
Homo sapiens Primates EGFR EGFR ncbigene_symbol EGFR 1956
Homo sapiens Primates IGFIR IGFIR ncbigene_synonym IGF1R 3480
Homo sapiens Primates INSR INSR ncbigene_symbol INSR 3643
Homo sapiens Primates INSR INSR famplex_relations INSRR 3645
Homo sapiens Primates KRAS KRAS ncbigene_symbol KRAS 3845
Homo sapiens Primates KRAS KRAS ncbigene_synonym NRAS 4893
Mus musculus Rodents EGFR EGFR ncbigene_symbol Egfr 13649
Mus musculus Rodents INSR INSR ncbigene_symbol Insr 16337
Mus musculus Rodents KRAS KRAS ncbigene_symbol Kras 16653

Chemical mentions

Word Match MeSH Name ChEBI

Disease mentions

Word Match MeSH Name DOID